FEATURED PRODUCTS

• Protein L Resin For Affinity Capture

  MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.

• Hyclone Cell Boost Supplements

  Supplements cell culture with amino acids, vitamins, and glucose and manufactured to meet cGMP manufacturing standards and QC specifications.

• Chromatography Systems

  ÄKTA™ chromatography systems can handle both simple and complex purification tasks and accelerate daily routines. All systems are controlled by UNICORN™ software, a common control platform and user interface for all scales of operation. 

• Bioprocessing Filtration

  Cytiva provides filtration solutions and support for integrated bioprocessing applications at every step and every scale of the drug development, validation and manufacturing process.

• Label-Free Interaction Analytics

  We offer a range of systems, accessories, and reagents for label-free analysis using microcalorimetry or surface plasmon resonance (SPR). These techniques provide information-rich, real time data without the use of labels.

• A High-Capacity Chromatography Resin For Robust mAb Capture

  Protein A chromatography resin with excellent capacity and alkaline stability for cost-efficient and extremely robust mAb capture.

• Drug Product Filtration System

  Automated PUPSIT and sterile filtration with enhanced product recovery.

• ReadyToProcess WAVE™ 25 Bioreactor System

  The ReadyToProcess WAVE 25 rocker features integrated temperature sensors and load cells, designed for convenient handling and control of cell cultures up to 25 L. A filter heater is delivered with the system.

• Protein A Resin With High Binding Capacity

  Protein A resin with high binding capacity for cost-efficient separation mAbs.

• Modular Environments For Biomanufacturing Capacity

  Accelerate your biomanufacturing capacity with purpose-built modules

  KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.